Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Glycomimetics Inc (GLYC)

Glycomimetics Inc (GLYC)
0.1999 +0.0077 (+4.01%) 13:45 ET [NASDAQ]
0.1944 x 40 0.1998 x 4
Realtime by (Cboe BZX)
0.1944 x 40 0.1998 x 4
Realtime 0.1953 +0.0031 (-) 09:22 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.1901
Day High
0.2040
Open 0.1980
Previous Close 0.1922 0.1922
Volume 123,988 123,988
Avg Vol 283,524 283,524
Stochastic %K 18.66% 18.66%
Weighted Alpha -72.89 -72.89
5-Day Change +0.0093 (+5.02%) +0.0093 (+5.02%)
52-Week Range 0.1406 - 2.5700 0.1406 - 2.5700
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,400
  • Shares Outstanding, K 64,514
  • Annual Sales, $ 0 K
  • Annual Income, $ -37,880 K
  • EBIT $ -40 M
  • EBITDA $ -40 M
  • 60-Month Beta 1.74
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.23
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.43
  • Most Recent Earnings $-0.11 on 02/13/25
  • Next Earnings Date 05/08/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Options Overview Details

View History
  • Implied Volatility 343.27% ( -13.94%)
  • Historical Volatility 69.34%
  • IV Percentile 65%
  • IV Rank 25.47%
  • IV High 1,196.80% on 07/09/24
  • IV Low 51.53% on 07/17/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 113
  • Put/Call OI Ratio 0.61
  • Today's Open Interest 6,914
  • Open Int (30-Day) 7,681

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +587,747.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1704 +14.08%
on 04/07/25
Period Open: 0.2610
0.2850 -31.79%
on 03/20/25
-0.0666 (-25.52%)
since 03/10/25
3-Month
0.1704 +14.08%
on 04/07/25
Period Open: 0.2650
0.3700 -47.46%
on 02/18/25
-0.0706 (-26.64%)
since 01/10/25
52-Week
0.1406 +38.26%
on 10/09/24
Period Open: 2.4500
2.5700 -92.44%
on 04/11/24
-2.2556 (-92.07%)
since 04/10/24

Most Recent Stories

More News
Top 5 Biotech Stocks That Got Most Retail Buzz Last Week

From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.

GRAL : 22.99 (-7.67%)
ADMA : 18.84 (-2.84%)
EXEL : 34.51 (-2.35%)
GLYC : 0.1999 (+4.01%)
MBRX : 0.7399 (-3.31%)
GlycoMimetics: Q3 Earnings Snapshot

GlycoMimetics: Q3 Earnings Snapshot

GLYC : 0.1999 (+4.01%)
GlycoMimetics: Q1 Earnings Snapshot

GlycoMimetics: Q1 Earnings Snapshot

GLYC : 0.1999 (+4.01%)
GlycoMimetics: Q4 Earnings Snapshot

GlycoMimetics: Q4 Earnings Snapshot

GLYC : 0.1999 (+4.01%)
GlycoMimetics: Q3 Earnings Snapshot

GlycoMimetics: Q3 Earnings Snapshot

GLYC : 0.1999 (+4.01%)
GlycoMimetics: Q2 Earnings Snapshot

GlycoMimetics: Q2 Earnings Snapshot

GLYC : 0.1999 (+4.01%)
GlycoMimetics: Q1 Earnings Snapshot

GlycoMimetics: Q1 Earnings Snapshot

GLYC : 0.1999 (+4.01%)
GlycoMimetics Reports Highlights and Financial Results for First Quarter 2023

GlycoMimetics, Inc. (Nasdaq: GLYC) a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today reported its financial...

GLYC : 0.1999 (+4.01%)
GlycoMimetics to Report First Quarter 2023 Financial Results on May 3, 2023

GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report first quarter 2023 financial results on Wednesday, May 3, 2023, at 8:30 a.m. ET.

GLYC : 0.1999 (+4.01%)
GlycoMimetics: Q4 Earnings Snapshot

GlycoMimetics: Q4 Earnings Snapshot

GLYC : 0.1999 (+4.01%)

Business Summary

GlycoMimetics, Inc. is a biotechnology company. The company focused on the discovery and development of novel glycomimetic drugs to address diseases in which carbohydrate biology plays a key role. It product pipeline includes GMI-170, GMI-1271, E-selectin and CXCR4 antagonist, GMI-1051 and GMI-1070 at...

See More

Key Turning Points

3rd Resistance Point 0.2342
2nd Resistance Point 0.2186
1st Resistance Point 0.2054
Last Price 0.1999
1st Support Level 0.1766
2nd Support Level 0.1610
3rd Support Level 0.1478

See More

52-Week High 2.5700
Fibonacci 61.8% 1.6420
Fibonacci 50% 1.3553
Fibonacci 38.2% 1.0686
Last Price 0.1999
52-Week Low 0.1406

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar